{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal stem Bronchopulmonary Dysplasia",
            "NStudiesAvail": 430108,
            "NStudiesFound": 21,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 21,
            "FieldList": [
                  "OverallOfficialName",
                  "OverallOfficialRole",
                  "OverallStatus",
                  "OversightHasDMC",
                  "PatientRegistry",
                  "Phase",
                  "PointOfContactEMail",
                  "PointOfContactOrganization",
                  "PointOfContactPhone",
                  "PointOfContactPhoneExt",
                  "PointOfContactTitle",
                  "PrimaryCompletionDate",
                  "PrimaryCompletionDateType",
                  "PrimaryOutcomeDescription",
                  "PrimaryOutcomeMeasure",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OverallOfficialName": [
                              "Zhou Fu"
                        ],
                        "OverallOfficialRole": [
                              "Study Chair"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "June 1, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "the accumulative duration of oxygen therapy"
                        ],
                        "NCTId": [
                              "NCT03601416"
                        ]
                  },
                  {
                        "Rank": 2,
                        "OverallOfficialName": [
                              "Zhou Fu"
                        ],
                        "OverallOfficialRole": [
                              "Study Chair"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "December 31, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of participants with adverse reactions related to infusion after treatment"
                        ],
                        "NCTId": [
                              "NCT03558334"
                        ]
                  },
                  {
                        "Rank": 3,
                        "OverallOfficialName": [
                              "Chen Chao, PhD,MD"
                        ],
                        "OverallOfficialRole": [
                              "Study Director"
                        ],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "October 30, 2022"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Temporal profiles of the fraction of inspiration oxygen 3 days after transplantation, the tolerable required oxygen \uff0cwhich is the minimum fraction of inspiration oxygen in which the participants has a stable SpO2 (90%-95%), measured in %"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Oxygen requirement 3 days after transplantation"
                        ],
                        "NCTId": [
                              "NCT03645525"
                        ]
                  },
                  {
                        "Rank": 4,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "November 30, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Incidence of the adverse events or serious adverse events after transplantation",
                              "To identify the proportion of patient with Bronchopulmonary Dysplasia win from oxygen after stem cell transplantation."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Adverse events and serious adverse events",
                              "The proportion of patients win from oxygen"
                        ],
                        "NCTId": [
                              "NCT04062136"
                        ]
                  },
                  {
                        "Rank": 5,
                        "OverallOfficialName": [
                              "Maria Jesus del Cerro, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Active, not recruiting"
                        ],
                        "OversightHasDMC": [
                              "No"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "April 2, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Number of participants with adverse events as a measure of safety and tolerability"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Feasibility and security of MSC therapy in very low birth weight preterm babies at risk of developing bronchopulmonary dysplasia (Number of participants with adverse events)"
                        ],
                        "NCTId": [
                              "NCT02443961"
                        ]
                  },
                  {
                        "Rank": 6,
                        "OverallOfficialName": [
                              "Zhou Fu"
                        ],
                        "OverallOfficialRole": [
                              "Study Chair"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "July 1, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [
                              "Readmission rate",
                              "Duration of the hospital stay due to respiratory infection"
                        ],
                        "NCTId": [
                              "NCT03873506"
                        ]
                  },
                  {
                        "Rank": 7,
                        "OverallOfficialName": [
                              "Jie Yang, PHD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "No"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "August 1, 2019"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "incidence of BPD"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "number of patients with BPD after instillation mesenchymal stem cells"
                        ],
                        "NCTId": [
                              "NCT03683953"
                        ]
                  },
                  {
                        "Rank": 8,
                        "OverallOfficialName": [
                              "Bai-Horng Su, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "June 2012"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "To examine the relations between the cytokine concentrations in the BAL fluid and PAP."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "The relations between the cytokine concentrations in the BAL fluid and PAP."
                        ],
                        "NCTId": [
                              "NCT01207869"
                        ]
                  },
                  {
                        "Rank": 9,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Early Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "December 30, 2022"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "the infant is dead due to lung disease"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "death"
                        ],
                        "NCTId": [
                              "NCT03378063"
                        ]
                  },
                  {
                        "Rank": 10,
                        "OverallOfficialName": [
                              "Zhou Fu"
                        ],
                        "OverallOfficialRole": [
                              "Study Chair"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "December 1, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "To evaluate the safety of hUC-MSCs for BPD."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of participants with adverse reactions related to infusion after treatment"
                        ],
                        "NCTId": [
                              "NCT03774537"
                        ]
                  },
                  {
                        "Rank": 11,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Active, not recruiting"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "December 31, 2022"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "\u2022 The incidence and frequency of adverse events (AEs) and serious adverse events (SAEs), including their relationship to the administration of UMC119 01."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "The incidence and frequency of adverse events related to administration of UMC119-01."
                        ],
                        "NCTId": [
                              "NCT03631420"
                        ]
                  },
                  {
                        "Rank": 12,
                        "OverallOfficialName": [
                              "Steven Powell, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "September 2016"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [
                              "Number of participants with adverse reactions for 84 days after treatment"
                        ],
                        "NCTId": [
                              "NCT02381366"
                        ]
                  },
                  {
                        "Rank": 13,
                        "OverallOfficialName": [
                              "Won-Soon Park, M.D., PhD."
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "September 2011"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Number of paitents with normal rage of vital signs and laboratory examination Chest x-ray result, Duration of ventilator dependence, Duration of CPAP treatment, Duration of intubation, Occurrence of pneumothorax, Occurrence of intraventricular hemorrhage, Postnatal steroid use (%), Dose of surfactant (%) Cumulative duration of oxygen use"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of participant with adverse reaction"
                        ],
                        "NCTId": [
                              "NCT01297205"
                        ]
                  },
                  {
                        "Rank": 14,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Terminated"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [
                              "clinicaltrials@unither.com"
                        ],
                        "PointOfContactOrganization": [
                              "United Therapeutics Corp."
                        ],
                        "PointOfContactPhone": [
                              "919-485-8350"
                        ],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [
                              "Global Medical Information"
                        ],
                        "PrimaryCompletionDate": [
                              "May 20, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "The safety and tolerability of UNEX-42 in subjects with BPD was evaluated by the number of subjects with treatment-emergent adverse events, including death, computed by dose cohort and overall during the Post-treatment Phase."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of Subjects With Treatment-emergent Adverse Events During the Post-treatment Phase (Safety and Tolerability)"
                        ],
                        "NCTId": [
                              "NCT03857841"
                        ]
                  },
                  {
                        "Rank": 15,
                        "OverallOfficialName": [
                              "Won-Soon Park, MD, PhD",
                              "Ai-Rhan Kim"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator",
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "May 2015"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Incidence of BPD (moderate to severe) or mortality rate at 36 weeks PMA"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Incidence of BPD (moderate to severe) or mortality at 36 weeks PMA"
                        ],
                        "NCTId": [
                              "NCT01828957"
                        ]
                  },
                  {
                        "Rank": 16,
                        "OverallOfficialName": [
                              "Won-Soon Park, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Active, not recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "September 2025"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Blood test, chest x-ray, physical exam"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of subjects with Adverse Drug Reaction"
                        ],
                        "NCTId": [
                              "NCT01632475"
                        ]
                  },
                  {
                        "Rank": 17,
                        "OverallOfficialName": [
                              "Wonsoon Park, MD, PhD",
                              "Ai-Rhan Kim, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator",
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "June 30, 2027"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection is recorded and compared with control group",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection",
                              "Total number of hospitalizations and the number of hospital stay due to respiratory infection"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations",
                              "Respiratory outcome: Number of hospitalizations"
                        ],
                        "NCTId": [
                              "NCT04003857"
                        ]
                  },
                  {
                        "Rank": 18,
                        "OverallOfficialName": [
                              "Wonsoon Park, MD, PhD",
                              "Ai-Rhan Kim, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator",
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Not Applicable"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "March 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [
                              "Respiratory outcome: readmission rate and duration of the hospital stay due to respiratory infection"
                        ],
                        "NCTId": [
                              "NCT01897987"
                        ]
                  },
                  {
                        "Rank": 19,
                        "OverallOfficialName": [
                              "Won-Soon Park, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "No"
                        ],
                        "PatientRegistry": [
                              "No"
                        ],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "October 2016"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "adverse drug reactions, clinically significant laboratory findings, vital signs, physical exam"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Number of subjects with adverse drug reactions"
                        ],
                        "NCTId": [
                              "NCT02023788"
                        ]
                  },
                  {
                        "Rank": 20,
                        "OverallOfficialName": [
                              "Wonsoon Park",
                              "Airhan Kim"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator",
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Unknown status"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "June 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Percentage of subjects who have severe BPD or are dead"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Percentage of subjects who have severe BPD or are dead"
                        ],
                        "NCTId": [
                              "NCT03392467"
                        ]
                  },
                  {
                        "Rank": 21,
                        "OverallOfficialName": [
                              "Bernard Th\u00e9baud, MD, PhD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Not yet recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "June 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Dose limiting toxicity consists of the following events:\n\nDeath occurring within 24 hours of injection;\nPulmonary embolism defined as acute increase in right ventricular afterload (identified by serial targeted neonatal echocardiography) and signs of acute increased dead space ventilation (respiratory distress, increased PaCO2, increased minute ventilation) occurring within 24 hours of injection;\nHypersensitivity / anaphylactic to uc-MSCs defined as any severe systemic inflammatory response syndrome with negative blood culture not consistent with the overall clinical course of the infant occurring within 72 hours of injection;\nAny other serious adverse event not expected in this patient population for which there is no alternative explanation but the administration of uc-MSCs, occurring within 1 week of injection."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Occurrence and rate of dose limiting toxicity"
                        ],
                        "NCTId": [
                              "NCT04255147"
                        ]
                  }
            ]
      }
}